Document Detail


IgM amyloidosis: clinical features in therapeutic outcomes.
MedLine Citation:
PMID:  21454218     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
It is not widely recognized that patients with amyloidosis may be associated with an IgM monoclonal protein. We reviewed the characteristics of 22 IgM amyloidosis patients seen at Mayo Clinic from 1989 through 2010 and uniformly treated with stem cell transplantation. IgM patients are older, have a higher prevalence of neuropathy, a lower incidence of cardiac involvement (lower troponin T and NT-proBNP), and a much lower level of the involved immunoglobulin free light chain.
Authors:
Morie A Gertz; Francis K Buadi; Suzanne R Hayman
Related Documents :
16377368 - Substance abuse and recovery in a psychiatric intensive care unit.
20571458 - Abnormal regional homogeneity of drug-naïve obsessive-compulsive patients.
8708658 - A brazilian cohort of patients with tourette's syndrome.
6144458 - Benzodiazepines in the treatment of acute anxiety.
11101738 - Currarino triad--diagnostic dilemma and a combined surgical approach.
2240748 - Tetanus immunization status and immunologic response to a booster in an emergency depar...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinical lymphoma, myeloma & leukemia     Volume:  11     ISSN:  2152-2669     ISO Abbreviation:  Clin Lymphoma Myeloma Leuk     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-04-01     Completed Date:  2011-08-30     Revised Date:  2011-10-03    
Medline Journal Info:
Nlm Unique ID:  101525386     Medline TA:  Clin Lymphoma Myeloma Leuk     Country:  United States    
Other Details:
Languages:  eng     Pagination:  146-8     Citation Subset:  IM    
Affiliation:
Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA. gertz.morie@mayo.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amyloidosis / drug therapy,  immunology*,  therapy*
Female
Humans
Immunoglobulin M / immunology*
Male
Stem Cell Transplantation
Treatment Outcome
Chemical
Reg. No./Substance:
0/Immunoglobulin M

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Treatment of IgM-associated AL amyloidosis with the combination of rituximab, bortezomib, and dexame...
Next Document:  Update in indolent non-Hodgkin lymphoma (NHL): paradigm for Waldenström's macroglobulinemia (WM).